PAVLASOVÁ, Gabriela, Marek BORSKÝ, Veronika SVOBODOVÁ, Kateřina MUSILOVÁ, Kateřina ČERNÁ, Václav ŠEDA, Jitka NOVOTNÁ, Yvona BRYCHTOVÁ, Michael DOUBEK, Šárka POSPÍŠILOVÁ, Jiří MAYER and Marek MRÁZ. BCR signalling proficient chronic lymphocytic leukaemia cells are prone to rituximab mediated elimination in vivo. In 22nd EHA Annual Congress; Madrid, Spain, červen 2017 in Haematologica 2017. 2017. |
Other formats:
BibTeX
LaTeX
RIS
@proceedings{1397349, author = {Pavlasová, Gabriela and Borský, Marek and Svobodová, Veronika and Musilová, Kateřina and Černá, Kateřina and Šeda, Václav and Novotná, Jitka and Brychtová, Yvona and Doubek, Michael and Pospíšilová, Šárka and Mayer, Jiří and Mráz, Marek}, booktitle = {22nd EHA Annual Congress; Madrid, Spain, červen 2017 in Haematologica 2017}, keywords = {BCR; CLL; rituximab}, language = {eng}, title = {BCR signalling proficient chronic lymphocytic leukaemia cells are prone to rituximab mediated elimination in vivo.}, year = {2017} }
TY - CONF ID - 1397349 AU - Pavlasová, Gabriela - Borský, Marek - Svobodová, Veronika - Musilová, Kateřina - Černá, Kateřina - Šeda, Václav - Novotná, Jitka - Brychtová, Yvona - Doubek, Michael - Pospíšilová, Šárka - Mayer, Jiří - Mráz, Marek PY - 2017 TI - BCR signalling proficient chronic lymphocytic leukaemia cells are prone to rituximab mediated elimination in vivo. KW - BCR KW - CLL KW - rituximab N2 - BCR signalling proficient chronic lymphocytic leukaemia cells are prone to rituximab mediated elimination in vivo., BCR signalling proficient chronic lymphocytic leukaemia cells are prone to rituximab mediated elimination in vivo. ER -
PAVLASOVÁ, Gabriela, Marek BORSKÝ, Veronika SVOBODOVÁ, Kateřina MUSILOVÁ, Kateřina ČERNÁ, Václav ŠEDA, Jitka NOVOTNÁ, Yvona BRYCHTOVÁ, Michael DOUBEK, Šárka POSPÍŠILOVÁ, Jiří MAYER and Marek MRÁZ. BCR signalling proficient chronic lymphocytic leukaemia cells are prone to rituximab mediated elimination in vivo. In \textit{22nd EHA Annual Congress; Madrid, Spain, červen 2017 in Haematologica 2017}. 2017.
|